- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/66 - One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulfur, or nitrogen atom, e.g. pyridoxal
Patent holdings for IPC class C07D 213/66
Total number of patents in this class: 26
10-year publication summary
|
2
|
1
|
3
|
0
|
1
|
3
|
0
|
3
|
4
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Abbvie Inc. | 1836 |
4 |
| Calico Life Sciences LLC | 107 |
4 |
| Cellix Bio Private Limited | 52 |
2 |
| PI Industries Ltd | 196 |
2 |
| Celagenex Research (India) PVT. LTD. | 61 |
2 |
| Alexander Shulgin Research Institute, Inc. | 28 |
2 |
| Albireo AB | 176 |
1 |
| Gwangju Institute of Science and Technology | 829 |
1 |
| Indigene Pharmaceuticals, Inc. | 8 |
1 |
| Shin Poong Pharmaceutical Co., Ltd. | 41 |
1 |
| Tokai University Educational System | 171 |
1 |
| Zhejiang Nhu Company Limited | 193 |
1 |
| Geneheal Biotechnology Co., Ltd. | 30 |
1 |
| Link Technologies Limited | 1 |
1 |
| Shandong Nhu Fine Chemical Science and Technology Company Ltd. | 18 |
1 |
| Lamacics Co., Ltd. | 2 |
1 |
| Other owners | 0 |